Stock TEVJF TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

News Teva Pharmaceutical Industries Limited OTC Markets

Equities

TEVJF

IL0006290147

Market Closed - OTC Markets
Other stock markets
 11:32:46 25/06/2024 pm IST 		5-day change 1st Jan Change
14.7 USD -18.33% Intraday chart for Teva Pharmaceutical Industries Limited -18.33% +70.53%
27/06 Jefferies Adjusts Price Target on Teva Pharmaceutical Industries to $23 From $19, Maintains Buy Rating MT
25/06 Global markets live: UBS, Boeing, AT&T, Rivian, Nvidia, Tesla... Our Logo

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
New AJOVY® (fremanezumab) Migraine Prevention Data Challenges Treatment Pauses
BU
Jefferies Adjusts Price Target on Teva Pharmaceutical Industries to $23 From $19, Maintains Buy Rating
MT
Global markets live: UBS, Boeing, AT&T, Rivian, Nvidia, Tesla...
Our Logo
Teva Pharmaceutical Pays $750 Million to Resolve Tax-Related Litigation
MT
Teva settles tax dispute in Israel with $750 mln payment
RE
Teva Announces Launch of Authorized Generic of Victoza, in the United States
AQ
Teva Reaches Agreement With the Israel Tax Authority to Resolve All Pending Litigation for the Company's Taxable Years 2008-2020
BU
Teva Reaches Agreement With the Israel Tax Authority to Resolve All Pending Litigation for the Company's Taxable Years 2008-2020
CI
Teva Pharmaceutical Launches Generic Victoza in US
MT
Teva Announces Launch of Authorized Generic of Victoza® (liraglutide injection 1.8mg), in the United States
BU
Teva Pharmaceutical Industries Limited Announces Launch of Authorized Generic of Victoza® (Liraglutide Injection 1.8Mg), in the United States
CI
Teva Pharmaceutical Industries 'Well-Positioned' for Further Growth, UBS Says
MT
Global markets live: Tesco, Adobe, Tyson Foods, GameStop, Teva...
Our Logo
Teva Pharmaceutical Sues Corcept Therapeutics Alleging Market Monopolization for Cushing's Syndrome Drug Korlym
MT
Transcript : Teva Pharmaceutical Industries Limited Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-11-2024 08:00 AM
Barclays Adjusts Price Target on Teva Pharmaceutical Industries to $21 From $20, Maintains Overweight Rating
MT
Teva to Present at the Goldman Sachs 45th Annual Global Healthcare Conference
BU
Teva Pharmaceuticals - New Data Provide Schizophrenia Treatment Insights into Switching to UZEDY Extended-Release Injectable Suspension from Invega Sustenna
AQ
New Data Provide Schizophrenia Treatment Insights into Switching to UZEDY® (risperidone) Extended-Release Injectable Suspension from Invega Sustenna® (paliperidone palmitate)
BU
Teva Presents First Real-World Data from the IMPACT-TD Registry Study at Psych Congress Elevate 2024
BU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. TEVA Stock
  4. TEVJF Stock
  5. News Teva Pharmaceutical Industries Limited